Macrophage Migration Inhibitory Factor mediates bladder pain
Macrophage Migration Inhibitory Factor mediates bladder pain
批准号:
9795728
负责人:
Pedro L Vera
金额:
$19.91万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-07-01 至 2023-06-30
关键词:
AcuteBindingBladderBladder InjuryCyclophosphamideCystitisDataGoalsHMGB1 ProteinHumanHyperalgesiaIn VitroInfectionInfective cystitisInflammationInflammatoryInjuryInterstitial CystitisKnowledgeMediatingMicrogliaMigration Inhibitory FactorOrganOutcomePainPathologyPatientsPelvic PainPeptidesPeripheralProductionProteinsPublishingResearchRodent ModelSignal PathwaySignal TransductionSpinalSpinal CordSymptomsTLR4 geneTestingTherapeuticTherapeutic InterventionUrothelial CellWorkbasebladder painchronic pelvic paincytokineinhibitor/antagonistinterstitialnew therapeutic targetnovelpreventprotease-activated receptor 4radiation cystitisreceptortargeted treatmenttherapeutic target
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Our long-term goal is to discover novel therapeutic targets for pelvic pain. Pelvic pain,
bladder pain specifically, is also the cardinal symptom of interstitial cystitis/bladder pain
syndrome (IC/BPS) where most patients show no underlying bladder infection, pathology, or
injury. The local and central mechanisms that mediate pelvic pain are not fully understood.
There is an urgent need to correct this knowledge gap so as to develop effective novel
therapeutic targets for chronic pelvic pain.
Our overall objective in this application is to determine the mechanisms of MIF-
mediated bladder hyperalgesia. Our central hypothesis is that MIF mediates bladder
hyperalgesia through local (bladder) and central (spinal) mechanisms.
We plan to test our central hypothesis by pursuing the following three specific aims:
1. Identify urothelial MIF receptors that mediate bladder hyperalgesia.
Based on the published data referred to above, our working hypothesis is that released MIF
acts at urothelial MIF receptors to elicit urothelial HMGB1 release and bladder hyperalgesia.
2. Identify downstream targets of MIF/HMGB1 that mediate bladder hyperalgesia. Our
working hypothesis, based on our published and preliminary evidence, is that blocking
downstream signaling pathways activated by MIF/HMGB1 will prevent bladder hyperalgesia.
3. Identify spinal mechanisms that mediate persistent bladder hyperalgesia.
Based on our preliminary data, our working hypothesis is that increased production and
release of spinal MIF activates increased release of spinal HMGB1 to maintain bladder pain.
In order to accomplish these aims we will conduct studies using rodent models of
bladder pain and in vitro studies using human urothelial cells. We will examine organ-level
and spinal-level mechanisms of bladder pain while focusing on treating persistent bladder
pain. We will also identify novel lumbosacral peptides/proteins associated with persistent
bladder pain.
Succesful completion of these studies is expected to have a positive impact
because it is probable that the identified components of the mechanism will provide new
peripheral and/or central targets for therapeutic interventions in conditions of bladder pain.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Macrophage Migration Inhibitory Factor mediates bladder pain
-
批准号:10172892
-
项目类别:
-
资助金额:$27.39万
-
财政年份:2019
-
负责人:Pedro L Vera
-
依托单位:
MIF: a pro-inflammatory cytokine as a novel target to reduce bladder inflammation
-
批准号:9027836
-
项目类别:
-
资助金额:$25.01万
-
财政年份:2012
-
负责人:Pedro L Vera
-
依托单位:
MIF: a pro-inflammatory cytokine as a novel target to reduce bladder inflammation
-
批准号:8449587
-
项目类别:
-
资助金额:$24.14万
-
财政年份:2012
-
负责人:Pedro L Vera
-
依托单位:
MIF: a pro-inflammatory cytokine as a novel target to reduce bladder inflammation
-
批准号:8642175
-
项目类别:
-
资助金额:$25.01万
-
财政年份:2012
-
负责人:Pedro L Vera
-
依托单位:
MIF: a pro-inflammatory cytokine as a novel target to reduce bladder inflammation
-
批准号:8812803
-
项目类别:
-
资助金额:$25.01万
-
财政年份:2012
-
负责人:Pedro L Vera
-
依托单位:
MIF: a pro-inflammatory cytokine as a novel target to reduce bladder inflammation
-
批准号:8216525
-
项目类别:
-
资助金额:$25.01万
-
财政年份:2012
-
负责人:Pedro L Vera
-
依托单位:
Release of MIF protein complexes in vivo: response to inflammation
-
批准号:7286830
-
项目类别:
-
资助金额:$14.93万
-
财政年份:2006
-
负责人:Pedro L Vera
-
依托单位:
Release of MIF protein complexes in vivo: inflammation
-
批准号:7147846
-
项目类别:
-
资助金额:$17.63万
-
财政年份:2006
-
负责人:Pedro L Vera
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: